Symbiotic Capital EB Parallel Fund, L.P. logo
SEC Form D filing

Symbiotic Capital EB Parallel Fund, L.P.

Biotech · Regulation D 506(b) · CA · Filed March 11, 2025

Offering amount
Undisclosed
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
March 11, 2025
Signature date
CIK
0002013515

Summary

Symbiotic Capital Life Science fund; no offering amount but clear healthcare/biotech focus.

Source

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.